"Stellar results!"

QUMAS showed ongoing growth and profitability last year. QUMAS signed up 24 new customers for their compliance solutions including Tufts University, Sanquin Blood Supply Foundation, Siena Biotech, and several Fortune 100 companies in the Automotive, Banking, Energy, Insurance, and Technology sectors.

Kevin O'LearyKen Hayward

“It is always worth celebrating when a company grows as strongly as QUMAS did in 2009. Not only because of the number of new clients, but also because our core software sales grew by more than 20%. And all of this at a time when markets were severely under pressure,” said Kevin O’Leary, CEO. “Our profitability picture is a credit to an outstanding team who continue to focus on delivering great products to our rapidly growing client base. We are looking forward to a strong 2010 where we anticipate strong new client adoption across a broad range of markets.”

The company continued to invest heavily in R&D in 2009. New products launched last year included MyQUMAS 3.1, QUMAS DocCompliance 4.2, QUMAS ComplianceUnity and the QUMAS Biotechnology Package, a complete, web-based eDMS solution for biotechnology companies preparing for regulatory submissions that is delivered pre-configured and ready to use.

“Last year we focused on making our products easier to use and provided customers with the capability to configure dashboards on compliance activities across business units,” stated Ken Hayward, Chief Technology Officer of QUMAS. “In 2010 we will be focusing on extending our line of packaged solutions to help firms get up and running quickly with best-of-breed compliance solutions.”